Related references
Note: Only part of the references are listed.Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis
Sebastian F. N. Bode et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2023)
Longitudinal Magnetic Resonance Imaging Detects Onset and Progression of Chronic Rhinosinusitis from Infancy to School Age in Cystic Fibrosis
Lena Wucherpfennig et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles
Simon Y. Graeber et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
Amanda L. Stapleton et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaf tor/tezacaf tor/ivacaf tor therapy in adults with cystic fibrosis
Lena Wucherpfennig et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status Deep Learning CT Analysis and Patient-reported Outcomes
Daniel M. Beswick et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)
Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis
Emily DiMango et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study
Jordana E. Hoppe et al.
LANCET RESPIRATORY MEDICINE (2021)
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid
Jochen G. Mainz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
Jaehi Chung et al.
ANTIOXIDANTS (2021)
Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis
Simon Y. Graeber et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications
Marcus A. Mall et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Magnetic Resonance Imaging Detects Chronic Rhinosinusitis in Infants and Preschool Children with Cystic Fibrosis
Olaf Sommerburg et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS) A Randomized, Double-Blind, Controlled Study
Mirjam Stahl et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis
Simon Y. Graeber et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis
Mirjam Stahl et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Endoscopic Management of Paranasal Sinus Mucoceles: Meta-analysis of Visual Outcomes
Leonid M. Zukin et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Optical coherence tomography detects structural abnormalities of the nasal mucosa in patients with cystic fibrosis
Ute Oltmanns et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Progress in therapies for cystic fibrosis
Kris De Boeck et al.
LANCET RESPIRATORY MEDICINE (2016)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
Sebastien Boutin et al.
PLOS ONE (2015)
Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease
Mark O. Wielpuetz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Importance of bacteriology in upper airways of patients with Cystic Fibrosis
M. C. Berkhout et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients
Jacob Rasmussen et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis
J. G. Mainz et al.
THORAX (2009)
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis
S Hirtz et al.
GASTROENTEROLOGY (2004)
Paranasal sinus development: A radiographic study
RK Shah et al.
LARYNGOSCOPE (2003)